Can energetic vaccines, based on physics, be the sound options for
COVID-19 and other pandemics in the absence of pharmaceutical vaccines?
Abstract
The proposed approach presents substantial scientific evidence based on
physics and clinical data to support a clinical trial of an energetic
SARS-CoV-2 vaccine. This is particularly imperative in the absence of a
pharmaceutical vaccine as well as its uncertain future efficacy and
safety, considering the limited time for testing and rapid mutations of
the virus. Some of the vaccine trials have already been halted due to
volunteers falling ill. Physics and biophysics of the fundamental
electromagnetic nature of the living matter, including microbes as well
as water, support the imprinting of electromagnetic fields of microbes
in water that elicits an immune response. Energetic vaccines can be
rapidly mass-produced for both prophylaxis and treatment of the public
and healthcare personnel against the original as well as mutated viral
strains. These can be prepared through a standard homeopathic process,
as well as an energy field imprinting device,* offering a unique
potential in versatility, speed, and low cost in mass protection against
the current and future public health emergencies. Other viral
infections, epidemics, antibiotic-resistant, and vector-borne infections
could be similarly addressed. Paradoxically, in spite of a general
perception of homeopathy by physicians as the most alien and least
scientific, among complementary and alternative medicine (CAM), it is
just the opposite. Homeopathy carries formidable scientific support,
with the specific proposed homeopathic model being fully in line with
physicians’ superior knowledge of infectious diseases and medicine,
making its adaptation into their practice intuitive and more effective
than in the hands of non-MDs or DOs homeopaths. The practical advantage
of the proposed homeopathic model in acute infections versus its oldest
one of multisystemic, totality approach, yielding mixed results in
chronic diseases, parallels a similar prevailing success of the
corresponding conventional modalities in acute versus chronic diseases.